Here’s whether Edwards Lifesciences Corp (EW) is worth buying in 2026 —
based on weekly-updated price trend, RSI momentum, and return vs.
the S&P 500. Our current read: Bearish.
🔴
Bearish
Positives: 50-day MA is rising (+1.05% over 10 days). Concerns: trading below the 200-day MA (long-term downtrend); below the 50-day MA (medium-term momentum negative); RSI 9 — oversold. Currently 14.2% off its 52-week high. Score: -3/7.
EW is trading below its 200-day MA ($83.43) — a key warning sign the longer-term trend is under pressure. An RSI of 9.4 has dropped into oversold territory, which has historically preceded short-term bounces. The 1-year return of +9.0% compares to +16.5% for SPY (trailed the market by 7.5%).
$10,000 invested 1 year ago→ $10,901 today
vs. S&P 500 (SPY) — same period trailed market by 7.5%
1-Year Price Chart
Daily candles
MA-50MA-200UpDown
Signal Check
✗Above 200-day MA ($83.43)
✗Above 50-day MA ($87.25)
!RSI(14) neutral zone (30–70) — currently 9.4
✓Positive return (+9.0%)
!Within 10% of period high (−14.2%)
Period Range $82.63
$72.30$96.29
RSI (14) 9.4
0 · OversoldOverbought · 100
Key Metrics
Price$82.63
Period Return+9.0%
Period High$96.29
Period Low$72.30
Drawdown−14.2%
MA-50$87.25
MA-200$83.43
RSI (14)9.4
Avg Volume (30d)5.2M
vs. SPYtrailed by 7.5%
Return Rank#451 of 999
Trend Signals
Price is below the 200-day moving average ($83.43)